Thus, by blocking the Siglec-G/CD47 interaction, C11 aims to prevent neutrophil-mediated trogocytosis of B-1a cells, thereby preserving their immunomodulatory function and mitigating sepsis-induced inflammation. This evidence concerns the gene CD47 and Sepsis.